BCM
THC icon

Bridgeway Capital Management’s Tenet Healthcare THC Stock Holding History

Bridgeway Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
16,860
+7,120
+73% +$1.31M 0.06% 429
2026
Q1 		$1.84M Sell
9,740
-5,120
-34% -$1.08M 0.04% 545
2025
Q4 		$2.95M Buy
14,860
+700
+5% +$141K 0.06% 394
2025
Q3 		$2.88M Hold
14,160
– – 0.06% 426
2025
Q2 		$2.49M Sell
14,160
-340
-2% -$51.2K 0.06% 440
2025
Q1 		$1.95M Sell
14,500
-1,200
-8% -$158K 0.05% 504
2024
Q4 		$1.98M Sell
15,700
-16,900
-52% -$2.51M 0.04% 520
2024
Q3 		$5.42M Buy
+32,600
New +$4.93M 0.12% 258
2022
Q3 		– Sell
-39,900
Closed -$2.1M – 1451
2022
Q2 		$2.1M Sell
39,900
-44,200
-53% -$3.08M 0.05% 529
2022
Q1 		$7.23M Hold
84,100
– – 0.14% 251
2021
Q4 		$6.87M Buy
+84,100
New +$6.15M 0.13% 259
2014
Q1 		– Sell
-59,200
Closed -$2.49M – 1458
2013
Q4 		$2.49M Sell
59,200
-60,100
-50% -$2.62M 0.08% 382
2013
Q3 		$4.91M Sell
119,300
-4,000
-3% -$167K 0.17% 114
2013
Q2 		$5.68M Buy
+123,300
New +$5.52M 0.23% 65

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bridgeway Capital Management's THC Position: Q2 2026 in Review

Bridgeway Capital Management increased its Tenet Healthcare (THC) stake by 73% in Q2 2026, buying an estimated $1.31M and bringing the position to 16,860 shares worth $3.15M. The position accounts for 0.06% of the portfolio, ranked #429.

Bridgeway Capital Management first reported a position in THC in Q2 2013 and has held it in 14 quarters since. The position peaked at $7.23M in Q1 2022. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Bridgeway Capital Management held 16,860 shares of Tenet Healthcare worth $3.15M as of Q2 2026.
  • Bridgeway Capital Management bought 7,120 Tenet Healthcare shares in Q2 2026, an estimated $1.31M.
  • Tenet Healthcare made up 0.06% of Bridgeway Capital Management's portfolio in Q2 2026, its #429 holding.
  • Bridgeway Capital Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 14 quarters since.
  • Bridgeway Capital Management's Tenet Healthcare position peaked at $7.23M in Q1 2022.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.